10 -

10 - von Pawel J, Gatzemeier U, Pujol JL et al. Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer. J Clin Oncol 2001; 19(6):1743-1749.